logo

KRYS

Krystal Biotech·NASDAQ
--
--(--)
--
--(--)

KRYS fundamentals

Krystal Biotech (KRYS) released its earnings on Nov 3, 2025: revenue was 97.80M (YoY +16.65%), beat estimates; EPS was 2.66 (YoY +192.31%), beat estimates.
Revenue / YoY
97.80M
+16.65%
EPS / YoY
2.66
+192.31%
Report date
Nov 3, 2025
KRYS Earnings Call Summary for Q3,2025
  • Revenue Growth: Q3 Vyjuvek revenue $97.8M, up 15% QoQ, with 615 U.S. reimbursement approvals and 450+ prescribers.
  • Gross Margin Boost: 96% gross margin (vs 93% Q2) from U.S. manufacturing efficiencies; ex-U.S. margins to normalize as process awaits EU approval.
  • Pipeline Momentum: 4 CF null patient molecular data readout by year-end; NK trial enrollment underway; new HHD program IND cleared.
  • Global Expansion: Launched in Germany, France, Japan; distributor network expanding to CEE, ME.
EPS
Revenue

Revenue & Expenses

KRYS has released its 2025 Q3 earnings report, with revenue of 97.80M, reflecting a YoY change of 16.65%, and net profit of 79.36M, showing a YoY change of 192.00%. The Sankey diagram below clearly presents KRYS's revenue sources and cost distribution.

Key Indicators

Krystal Biotech (KRYS) key financial stats and ratios, covering profitability, financial health, and leverage.
Krystal Biotech (KRYS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Krystal Biotech (KRYS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Krystal Biotech (KRYS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Krystal Biotech (KRYS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Krystal Biotech (KRYS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield